TLR2 and TLR4 in Ischemia Reperfusion Injury
暂无分享,去创建一个
B. Keogh | A. Parker | F. Arslan | B. Keogh | P. Mcguirk | F. Arslan | P. McGuirk | A. E. Parker
[1] P. Doevendans,et al. Myocardial Ischemia / Reperfusion Injury Is Mediated by Leukocytic Toll-Like Receptor-2 and Reduced by Systemic Administration of a Novel Anti – Toll-Like Receptor-2 Antibody , 2009 .
[2] R. Colvin,et al. Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation , 2009, Proceedings of the National Academy of Sciences.
[3] F. Liew,et al. Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.
[4] F. Gao,et al. Toll‐Like Receptor and Heme Oxygenase‐1 Signaling in Hepatic Ischemia/Reperfusion Injury , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] M. Arditi,et al. Bacterial Lipopolysaccharide Activates NF-κB through Toll-like Receptor 4 (TLR-4) in Cultured Human Dermal Endothelial Cells , 2000, The Journal of Biological Chemistry.
[6] E. Marbán,et al. Molecular and cellular mechanisms of myocardial stunning. , 1999, Physiological reviews.
[7] S. H. Kim,et al. Influence of Angiotensin II on Expression of Toll-like Receptor 2 and Maturation of Dendritic Cells in Chronic Cyclosporine Nephropathy , 2007, Transplantation.
[8] L. Becker. Myocardial Reperfusion Injury , 2004, Journal of Thrombosis and Thrombolysis.
[9] M. Robson. Toll-Like Receptors and Renal Disease , 2009, Nephron Experimental Nephrology.
[10] J. Vinten-johansen,et al. The role of neutrophils in myocardial ischemia-reperfusion injury. , 1999, Cardiovascular research.
[11] M. Moskowitz,et al. Early Release of HMGB-1 from Neurons after the Onset of Brain Ischemia , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[12] S. Akira,et al. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. , 2003, The Journal of clinical investigation.
[13] C. Schäfer,et al. The first minutes of reperfusion: a window of opportunity for cardioprotection. , 2004, Cardiovascular research.
[14] G. R. Carson,et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. , 1990, Science.
[15] J. Kalbfleisch,et al. Preconditioning with a TLR2 specific ligand increases resistance to cerebral ischemia/reperfusion injury , 2008, Journal of Neuroimmunology.
[16] G. McFadden,et al. Induction of Indefinite Cardiac Allograft Survival Correlates With Toll-Like Receptor 2 and 4 Downregulation After Serine Protease Inhibitor-1 (Serp-1) Treatment , 2007, Transplantation.
[17] J. Rao,et al. Over‐expression of Toll‐like receptors and their ligands in small‐for‐size graft , 2010, Hepatology research : the official journal of the Japan Society of Hepatology.
[18] D. Hirsch,et al. Functional integrity of proximal tubule cells. Effects of hypoxia and ischemia. , 1992, Journal of the American Society of Nephrology : JASN.
[19] S. Chadban,et al. TLR4 activation mediates kidney ischemia/reperfusion injury. , 2007, The Journal of clinical investigation.
[20] Chul-woo Yang,et al. Ischemia-Reperfusion Injury Activates Innate Immunity in Rat Kidneys , 2005, Transplantation.
[21] G. Ercolani,et al. Causes of early acute graft failure after liver transplantation: analysis of a 17‐year single‐centre experience , 2005, Clinical transplantation.
[22] P. Clavien,et al. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. , 1992, Transplantation.
[23] T. Billiar,et al. Mechanisms of Toll-Like Receptor 4 (TLR4)-Mediated Inflammation After Cold Ischemia/Reperfusion in the Heart , 2009, Transplantation.
[24] M. Weiser,et al. Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement , 1996, The Journal of experimental medicine.
[25] Hui Wang,et al. TLR2 mRNA upregulation in ischemic lobes in mouse partial hepatic ischemia/reperfusion injury model. , 2004, Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban.
[26] R. Gottlieb,et al. Heart mitochondria: gates of life and death. , 2008, Cardiovascular research.
[27] C M Gibson,et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. , 2000, JAMA.
[28] Megan Sykes,et al. Organ transplantation—how much of the promise has been realized? , 2005, Nature Medicine.
[29] M. Abreu,et al. Toll-like receptors (TLRs) and Nod-like receptors (NLRs) in inflammatory disorders. , 2009, Seminars in immunology.
[30] D. Mann,et al. Innate immunity mediates myocardial preconditioning through Toll-like receptor 2 and TIRAP-dependent signaling pathways. , 2010, American journal of physiology. Heart and circulatory physiology.
[31] S. Akira,et al. Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury. , 2007, American journal of physiology. Heart and circulatory physiology.
[32] D. Hearse,et al. Reperfusion-induced arrhythmias: mechanisms and prevention. , 1984, Journal of molecular and cellular cardiology.
[33] P. Hansen,et al. Role of neutrophils in myocardial ischemia and reperfusion. , 1995, Circulation.
[34] N. Gretz,et al. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling , 2010, Disease Models & Mechanisms.
[35] W. Buurman,et al. In Vivo Expression of Toll-Like Receptor 2 and 4 by Renal Epithelial Cells: IFN-γ and TNF-α Mediated Up-Regulation During Inflammation1 , 2002, The Journal of Immunology.
[36] J. Inserte,et al. Orphan targets for reperfusion injury. , 2009, Cardiovascular research.
[37] Zhang Jinxiang,et al. Bone marrow and non-bone marrow TLR4 regulates hepatic ischemia/reperfusion injury. , 2009, Biochemical and biophysical research communications.
[38] R. Lorenz,et al. Toll-like receptor 2 is protective of ischemia–reperfusion-mediated small-bowel injury in a murine model , 2008, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[39] C. Garlanda,et al. Resident Dendritic Cells Prevent Postischemic Acute Renal Failure by Help of Single Ig IL-1 Receptor-Related Protein1 , 2009, The Journal of Immunology.
[40] P. Halloran,et al. Local T cell responses induce widespread MHC expression. Evidence that IFN-gamma induces its own expression in remote sites. , 1992, Journal of immunology.
[41] Jinxiang Zhang,et al. Protection against hepatic ischemia/reperfusion injury via downregulation of toll-like receptor 2 expression by inhibition of Kupffer cell function. , 2005, World journal of gastroenterology.
[42] H. Li,et al. The role of toll-like receptors 2 and 4 in acute allograft rejection after liver transplantation. , 2007, Transplantation proceedings.
[43] Jun Ren,et al. Deficiency in TLR4 signal transduction ameliorates cardiac injury and cardiomyocyte contractile dysfunction during ischemia , 2009, Journal of cellular and molecular medicine.
[44] P. Doevendans,et al. Bridging innate immunity and myocardial ischemia/reperfusion injury: the search for therapeutic targets. , 2008, Current pharmaceutical design.
[45] U. Heemann,et al. Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury , 2010, Pediatric Nephrology.
[46] N. Mackman,et al. TLR2 Is Constitutively Expressed within the Kidney and Participates in Ischemic Renal Injury through Both MyD88-Dependent and -Independent Pathways1 , 2007, The Journal of Immunology.
[47] I. Barajon,et al. Effects of warm ischemia on valve endothelium. , 1997, The Annals of thoracic surgery.
[48] R. Bolli. Preconditioning: a paradigm shift in the biology of myocardial ischemia. , 2007, American journal of physiology. Heart and circulatory physiology.
[49] H. Wong,et al. Activation of hepatocytes by extracellular heat shock protein 72. , 2008, American journal of physiology. Cell physiology.
[50] M. Shimada,et al. Ischemic injury in liver transplantation: Difference in injury sites between warm and cold ischemia in rats , 1992, Hepatology.
[51] P. Matzinger. The Danger Model: A Renewed Sense of Self , 2002, Science.
[52] D. Greiner,et al. TLR Agonists Abrogate Costimulation Blockade-Induced Prolongation of Skin Allografts1 , 2006, The Journal of Immunology.
[53] E. Murphy,et al. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. , 2008, Physiological reviews.
[54] H. Lehrach,et al. TLR2 has a detrimental role in mouse transient focal cerebral ischemia. , 2007, Biochemical and biophysical research communications.
[55] S. Akira,et al. TLR Engagement Prevents Transplantation Tolerance , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[56] P. Doevendans,et al. Role of apoptosis in reperfusion injury. , 2004, Cardiovascular research.
[57] S. Akira,et al. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. , 2005, The Journal of clinical investigation.
[58] Yuan Tian,et al. N-acetylcysteine inhibits activation of toll-like receptor 2 and 4 gene expression in the liver and lung after partial hepatic ischemia-reperfusion injury in mice. , 2007, Hepatobiliary & pancreatic diseases international : HBPD INT.
[59] J. Kalbfleisch,et al. Differential roles of TLR2 and TLR4 in acute focal cerebral ischemia/reperfusion injury in mice , 2009, Brain Research.
[60] C. Ahn,et al. Cyclosporine-Induced Renal Injury Induces Toll-like Receptor and Maturation of Dendritic cells , 2005, Transplantation.
[61] Hiroshi Ito. No-reflow phenomenon and prognosis in patients with acute myocardial infarction , 2006, Nature Clinical Practice Cardiovascular Medicine.
[62] Polly Matzinger,et al. Friendly and dangerous signals: is the tissue in control? , 2007, Nature Immunology.
[63] M. Mattson,et al. Pivotal role for neuronal Toll-like receptors in ischemic brain injury and functional deficits , 2007, Proceedings of the National Academy of Sciences.
[64] V. Richard,et al. Toll-Like Receptors 2-Deficient Mice Are Protected Against Postischemic Coronary Endothelial Dysfunction , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[65] W. Rowiński,et al. Ischemia/reperfusion injury in kidney transplantation: mechanisms and prevention. , 2008, Transplantation proceedings.
[66] L. O’Neill,et al. How Toll-like receptors signal: what we know and what we don't know. , 2006, Current opinion in immunology.
[67] Bin Yang,et al. The Relative Effects of Warm and Cold Ischemic Injury in an Experimental Model of Nonheartbeating Donor Kidneys , 2008, Transplantation.
[68] K. Walley,et al. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response. , 2006, Cardiovascular research.
[69] T. van der Poll,et al. Toll-Like Receptor-4 Coordinates the Innate Immune Response of the Kidney to Renal Ischemia/Reperfusion Injury , 2008, PloS one.
[70] W. Baldwin,et al. Innate immune responses to transplants: a significant variable with cadaver donors. , 2001, Immunity.